WordNet
- the branch of medicine concerned with the study and treatment of tumors
- of or relating to or practicing oncology; "oncological nurse" (同)oncologic
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2017/11/11 10:22:37」(JST)
wiki en
Not to be confused with ontology, ontogeny, or odontology.
See cancer for the biology of the disease, as well as a list of malignant diseases.
"Clinical oncology" redirects here. For the medical journal, see Clinical Oncology.
|
This article is in a list format that may be better presented using prose. You can help by converting this article to prose, if appropriate. Editing help is available. (May 2017)
|
|
A coronal CT scan showing a malignant mesothelioma, indicated by the asterisk and the arrows
|
|
| Focus | Cancerous tumor |
|---|---|
| Subdivisions | Medical oncology, radiation oncology, surgical oncology |
| Significant tests | Tumor markers, TNM staging, CT scans, MRI |
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist.[1] The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass" and the word λόγος (logos), meaning "speech". [2]
The three components which have improved survival in cancer are:
- Prevention – by reduction of risk factors like tobacco and alcohol consumption[3]
- Early diagnosis – screening of common cancers[4] and comprehensive diagnosis and staging
- Treatment – multimodality management[5] by discussion in tumor board and treatment in a comprehensive cancer centre[6]
Cancers are often managed through discussion on multi-disciplinary cancer conferences[7] where medical oncologists, surgical oncologists, radiation oncologists, pathologists, radiologists and organ specific oncologists meet to find the best possible management for an individual patient considering the physical, social, psychological, emotional and financial status of the patient. It is very important for oncologists to keep updated with respect to the latest advancements in oncology, as changes in management of cancer are quite common. All eligible patients in whom cancer progresses and for whom no standard of care treatment options are available should be enrolled in a clinical trial.
Contents
- 1 Risk factors
- 2 Screening
- 3 Symptoms
- 4 Diagnosis and staging
- 4.1 Blood cancer
- 4.2 Lymphoma
- 4.3 Solid tumors
- 5 Treatment
- 5.1 Solid tumors
- 5.2 Lymphoma
- 5.3 Blood cancer
- 6 Specialties
- 7 Progress and future
- 8 See also
- 9 References
- 10 Bibliography
- 11 External links
Risk factors
- Tobacco
- It is the leading cause of cancer and of death from cancer. Smoking is associated with increased risk of cancers of lung, larynx, mouth, oesophagus, throat, bladder, kidney, liver, stomach, pancreas, colon, rectum, cervix and acute myeloid leukemia. Smokeless tobacco (snuff or chewing tobacco) is associated with increased risks of cancers of the mouth, oesophagus, and pancreas.[8]
- Alcohol
- It can increase your risk of cancer of the mouth, throat, oesophagus, larynx, liver and breast. The risk of cancer is much higher for those who drink alcohol and also use tobacco.[9]
- Obesity
- Obese individuals have an increased risk of cancers of breast, colon, rectum, endometrium, eosophagus, kidney, pancreas, and gallbladder.[10]
- Age
- Advanced age is a risk factor for many cancers. The median age of cancer diagnosis is 66 years.[11]
Screening
Screening is recommended for cancers of breast,[12] cervix,[13] colon[14] and lung.[15]
Symptoms
Symptoms usually depend on the site and type of cancer.
- Breast cancer
- Lump in breast and axilla associated with or without ulceration or bloody nipple discharge.[16]
- Endometrial cancer
- Bleeding per vagina.[17]
- Cervix cancer
- Bleeding after sexual intercourse.[18]
- Ovary cancer
- Nonspecific symptoms like abdominal distension, dyspepsia.[19]
- Lung cancer
- Persistent cough, breathlessness, blood in the sputum, hoarseness of voice.[20]
- Head and neck cancer
- Non-healing ulcer or growth, lump in the neck.[21]
- Brain cancer
- Persistent headache, vomiting, loss of consciousness, double vision.[22]
- Thyroid cancer
- Lump in the neck.[23]
- Oesophagus cancer
- Painful swallowing predominantly to solid food, weight loss.[24]
- Stomach cancer
- Vomiting, dyspepsia, weight loss.[25]
- Colon & rectal cancer
- Bleeding per rectum, alteration of bowel habits.[26]
- Liver cancer
- Jaundice, pain and mass in right upper abdomen.[27]
- Pancreatic cancer
- Weight loss, jaundice.[28]
- Skin cancer
- Non-healing ulcer or growth, mole with sudden increase in size, irregular border, induration or pain.[29]
- Kidney cancer
- Blood in urine, abdominal lump.[30]
- Bladder cancer
- Blood in urine.[31]
- Prostate cancer
- Urgency, hesitancy and frequency while passing urine, bony pain.[32]
- Testis cancer
- Swelling of testis, back pain, dyspnoea.[33]
- Bone cancer
- Pain and swelling of bones.[34]
- Lymphoma
- Fever, weight loss more than 10% body weight in preceding 6 months and drenching night sweats which constitutes the B symptoms, lump in neck, axilla or groin.[35]
- Blood cancer
- Bleeding manifestations including bleeding gums, bleeding from nose, blood in vomitus, blood in sputum, blood stained urine, black coloured stools, fever, lump in neck, axilla or groin, lump in upper abdomen.[20]
Diagnosis and staging
Diagnostic and staging investigations depend on the site and type of malignancy.
Blood cancer
Blood investigations including haemoglobin, total leukocyte count, platelet count, peripheral smear, red cell indices.
Bone marrow studies including aspiration, Flow-cytometry,[36] Cytogenetics,[37] Fluorescent in situ hybridisation and molecular studies.[38]
Lymphoma
Excision biopsy of lymph node for Histopathological Examination (HPE),[39] Immuno-histochemistry (IHC)[40] and molecular studies.[41]
Blood investigations including Lactate dehydrogenase (LDH), Serum Uric Acid, Renal Functions.[42]
Imaging tests like Computerised Tomography (CT), Positron emission tomography (PET CT).[43]
Bone marrow biopsy.[44]
Solid tumors
Biopsy for histopathology & IHC.[45]
Imaging tests like Roentgenogram (X-ray), Ultrasonography, Computerised tomography (CT), Magnetic Resonance Imaging (MRI) and PET CT.[46]
Endoscopy including Naso-pharyngoscopy, Direct & Indirect Laryngoscopy, Upper Gastrointestinal Endoscopy, Colonoscopy, Cystoscopy.
Tumor markers including alphafetoprotein (AFP),[47] Beta Human Chorionic Gonadotropin (HCG),[47] Carcinoembionic Antigen (CEA),[48] CA 125,[49] Prostate specific antigen (PSA).[50]
Treatment
Treatment depends on the site and type of cancer.
Solid tumors
- Breast cancer
- Treatment options include surgery, radiation, chemotherapy, hormonal therapy and targeted therapy (Her 2 neu inhibitors).[51]
- Cervix cancer
- Treatment options include radiation, surgery and chemotherapy.[52]
- Endometrial cancer
- Treatment options include surgery, radiation and chemotherapy.[53]
- Ovary cancer
- Treatment options include surgery, chemotherapy and targeted therapy (VEGF inhibitors).[54]
- Lung cancer
- Treatment options include surgery, radiation, chemotherapy and targeted therapy (EGFR & ALK inhibitors).[55]
- Head & Neck Cancer
- Treatment options include surgery, radiation, chemotherapy and targeted therapy (EGFR inhibitors).[56]
- Brain cancer
- Treatment options include surgery, radiation, chemotherapy and targeted therapy (VEGF inhibitors).[51]
- Thyroid cancer
- Treatment options include surgery and radioactive iodine.[57]
- Oesophageal cancer
- Treatment options include radiation, chemotherapy and surgery.[58]
- Stomach cancer
- Treatment options include chemotherapy, surgery, radiation and targeted therapy (Her 2 neu inhibitors).[59][60]
- Colon cancer
- Treatment options include surgery, chemotherapy and targeted therapy (EGFR & VEGF inhibitors).[61]
- Rectum cancer
- Treatment options include chemotherapy, radiation, surgery.[62]
- Liver cancer
- Treatment options include surgery, Trans-arterial chemotherapy (TACE), Radio-frequency abalation (RFA) and multi-kinase (Sorafenib).[63]
- Pancreas cancer
- Treatment options include surgery, radiation and chemotherapy.[64]
- Skin cancer
- Treatment options include surgery, radiation, targeted therapy (BRAF & MEK inhibitors), Immunotherapy (CTLA 4 & PD 1 inhibitors) and chemotherapy.[65]
- Kidney cancer
- Treatment options include surgery, multi-kinase inhibitors and targeted therapy (mTOR & VEGF inhibitors).[66]
- Bladder cancer
- Treatment options include surgery, radiation and chemotherapy.[67]
- Prostate cancer
- Treatment options include surgery, radiation, chemotherapy, anti-androgens and immunotherapy.[68]
- Testis cancer
- Treatment options include surgery, chemotherapy and radiation.[69]
- Bone cancer
- Treatment options include surgery, chemotherapy and radiation.[70]
Lymphoma
It includes Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL):
- Hodgkin lymphoma (HL)
- Chemotherapy with ABVD or BEACOPP regimen and Involved field radiation therapy (IFRT).[71]
- Non-Hodgkin lymphoma (NHL)
- Chemo-immunotherapy (R-CHOP) for B cell lymphomas and chemotherapy (CHOP) for T cell lymphomas.[72]
Blood cancer
Includes acute and chronic leukemias. Acute leukemias includes acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Chronic leukemias include chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML).
- Acute lymphoblastic leukemia (ALL)
- Intensive chemotherapy phase for initial 6 months and maintenance chemotherapy for 2 years. Prophylactic cranial and stem cell transplantation for high-risk patients.[73]
- Acute myeloid leukemia (AML)
- Induction with chemotherapy (Daunorubicin + Cytarabine) followed by consolidation chemotherapy (High dose cytarabine). Stem cell transplantation for high-risk patients.[74]
- Chronic lymphocytic leukemia (CLL): Chemo-immunotherapy (FCR or BR regimen) for symptomatic patients.[75]
- Chronic myeloid leukemia (CML)
- Targeted therapy with tyrosine kinase inhibitor (Imatinib) as first-line treatment.[76]
Specialties
- The three main divisions:
- Medical oncology: focuses on treatment of cancer with chemotherapy, targeted therapy, immunotherapy and hormonal therapy.[77]
- Surgical oncology: focuses on treatment of cancer with surgery.[78]
- Radiation oncology: focuses on treatment of cancer with radiation.[78]
- Sub-specialties in Oncology:
- Neuro-oncology: focuses on cancers of brain.
- Ocular oncology: focuses on cancers of eye.[79]
- Head & Neck oncology: focuses on cancers of oral cavity, nasal cavity, oropharynx, hypopharyx and larynx.[80]
- Thoracic oncology: focuses on cancers of lung, mediastinum, oesophagus and pleura.[81]
- Breast oncology: focuses on cancers of breast
- Gastrointestinal oncology: focuses on cancers of stomach, colon, rectum, anal canal, liver, gallbladder, pancreas.[82]
- Bone & Musculoskeletal oncology: focuses on cancers of bones and soft tissue.[83]
- Dermatological oncology: focuses on the medical and surgical treatment of skin, hair, sweat gland, and nail cancers
- Genitourinary oncology: focuses on cancers of genital and urinary system.[84]
- Gynecologic oncology: focuses on cancers of the female reproductive system.[85]
- Pediatric oncology: concerned with the treatment of cancer in children.[86]
- Hemato oncology: focuses on cancers of blood and stem cell transplantation
- Preventive oncology: focuses on epidemiology & prevention of cancer.[87]
- Geriatric oncology: focuses on cancers in elderly population.[88]
- Pain & Palliative oncology: focuses on treatment of end stage cancer to alleviate the suffering.[89]
- Molecular oncology: focuses on molecular diagnostic methods in oncology.[90]
- Oncopathology: A specialty of Pathology that focuses on the histopathological diagnosis of cancer. As a significant portion of all general pathology practice is concerned with cancer, the practice of oncology is deeply tied to, and dependent upon, the work of both anatomical and clinical pathologists.[78]
- Nuclear medicine oncology: focuses on diagnosis and treatment of cancer with radiopharmaceuticals.
- Psycho-oncology: focuses on psychosocial issues on diagnosis and treatment of cancer patients.
- Veterinary oncology: focuses on treatment of cancer in animals.[91]
Progress and future
- Leukemia,[92] Lymphoma,[93] Germ cell tumors[94] and early stage solid tumors which were once incurable have become curable malignancies now
- Survival of cancer has significantly improved over the past years due to improved screening, diagnostic methods and treatment options with targeted therapy.
- Large multi-centric Phase III randomised controlled clinical trials by the National Surgical Adjuvant Breast & Bowel Project (NSABP)[95] Medical Research Council (MRC),[96] the European Organisation for Research and Treatment of Cancer (EORTC),[97] and National Cancer Institute (NCI) have contributed significantly to the improvement in survival.
See also
- American Cancer Society
- American Cancer Society Cancer Action Network
- American Cancer Society Center
- American Society of Clinical Oncology
- Canadian Cancer Society
- Cancer Research UK
- National Cancer Institute
- National Comprehensive Cancer Network
- Programme of Action for Cancer Therapy
References
- ^ Maureen McCutcheon. Where Have My Eyebrows Gone?. Cengage Learning, 2001. ISBN 0766839346. Page 5.
- ^ Types of Oncologists, American Society of Clinical Oncology (ASCO).
- ^ Stein, C. J.; Colditz, G. A. (2004-01-26). "Modifiable risk factors for cancer". British Journal of Cancer. 90 (2): 299–303. doi:10.1038/sj.bjc.6601509. ISSN 0007-0920. PMC 2410150 . PMID 14735167.
- ^ Hristova, L.; Hakama, M. (1997-01-01). "Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017". Acta Oncologica. 36 Suppl 9: 1–60. ISSN 0284-186X. PMID 9143316.
- ^ Forbes, J. F. (1982-08-01). "Multimodality treatment of cancer". The Australian and New Zealand Journal of Surgery. 52 (4): 341–346. doi:10.1111/j.1445-2197.1982.tb06005.x. ISSN 0004-8682. PMID 6956307.
- ^ Bristow, Robert E.; Chang, Jenny; Ziogas, Argyrios; Campos, Belinda; Chavez, Leo R.; Anton-Culver, Hoda (2015-05-01). "Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival". Journal of the American College of Surgeons. 220 (5): 940–950. doi:10.1016/j.jamcollsurg.2015.01.056. ISSN 1879-1190. PMID 25840536.
- ^ Croke, J.M.; El-Sayed, S. (2012-08-01). "Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature". Current Oncology. 19 (4): e232–e238. doi:10.3747/co.19.944. ISSN 1198-0052. PMC 3410834 . PMID 22876151.
- ^ "Tobacco". National Cancer Institute. Retrieved 2016-01-18.
- ^ "Alcohol". National Cancer Institute. Retrieved 2016-01-18.
- ^ "Obesity". National Cancer Institute. Retrieved 2016-01-18.
- ^ "Age". National Cancer Institute. Retrieved 2016-01-18.
- ^ Gøtzsche, Peter C.; Jørgensen, Karsten Juhl (2013-01-01). "Screening for breast cancer with mammography". The Cochrane Database of Systematic Reviews. 6: CD001877. doi:10.1002/14651858.CD001877.pub5. ISSN 1469-493X. PMID 23737396.
- ^ Behtash, Nadereh; Mehrdad, Nili (2006-12-01). "Cervical cancer: screening and prevention". Asian Pacific Journal of Cancer Prevention. 7 (4): 683–686. ISSN 1513-7368. PMID 17250453.
- ^ Winawer, Sidney; Fletcher, Robert; Rex, Douglas; Bond, John; Burt, Randall; Ferrucci, Joseph; Ganiats, Theodore; Levin, Theodore; Woolf, Steven (2003-02-01). "Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence". Gastroenterology. 124 (2): 544–560. doi:10.1053/gast.2003.50044. ISSN 0016-5085. PMID 12557158.
- ^ Humphrey, Linda L.; Deffebach, Mark; Pappas, Miranda; Baumann, Christina; Artis, Kathryn; Mitchell, Jennifer Priest; Zakher, Bernadette; Fu, Rongwei; Slatore, Christopher G. (2013-09-17). "Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation". Annals of Internal Medicine. 159 (6): 411–420. doi:10.7326/0003-4819-159-6-201309170-00690. ISSN 1539-3704. PMID 23897166.
- ^ "Symptoms of Breast Cancer | Breastcancer.org". Breastcancer.org. Retrieved 2016-01-17.
- ^ Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Endometrial Cancer: Symptoms – National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Cervical Cancer: Symptoms – National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Olson, S. H.; Mignone, L.; Nakraseive, C.; Caputo, T. A.; Barakat, R. R.; Harlap, S. (2001-08-01). "Symptoms of ovarian cancer". Obstetrics and Gynecology. 98 (2): 212–217. doi:10.1016/s0029-7844(01)01457-0. ISSN 0029-7844. PMID 11506835.
- ^ a b Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Lung Cancer: Symptoms - National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Mehanna, H.; Paleri, V.; West, C. M. L.; Nutting, C. (2010-01-01). "Head and neck cancer—Part 1: Epidemiology, presentation, and prevention". BMJ (Clinical research ed.). 341: c4684. doi:10.1136/bmj.c4684. ISSN 1756-1833. PMID 20855405.
- ^ Snyder, H.; Robinson, K.; Shah, D.; Brennan, R.; Handrigan, M. (1993-06-01). "Signs and symptoms of patients with brain tumors presenting to the emergency department". The Journal of Emergency Medicine. 11 (3): 253–258. doi:10.1016/0736-4679(93)90042-6. ISSN 0736-4679. PMID 8340578.
- ^ Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Thyroid Cancer: Symptoms - National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Esophageal Cancer: Symptoms – National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Stomach Cancer (Gastric Cancer): Symptoms – National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Colon Cancer: Symptoms – National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Adult Primary Liver Cancer: Symptoms – National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Holly, Elizabeth A.; Chaliha, Indranushi; Bracci, Paige M.; Gautam, Manjushree (2004-06-01). "Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area". Clinical Gastroenterology and Hepatology. 2 (6): 510–517. doi:10.1016/s1542-3565(04)00171-5. ISSN 1542-3565. PMID 15181621.
- ^ Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Nonmelanoma Skin Cancer: Symptoms - National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Renal Cell Cancer: Symptoms – National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Shephard, Elizabeth A.; Stapley, Sally; Neal, Richard D.; Rose, Peter; Walter, Fiona M.; Hamilton, William T. (2012-09-01). "Clinical features of bladder cancer in primary care". The British Journal of General Practice: The Journal of the Royal College of General Practitioners. 62 (602): e598–604. doi:10.3399/bjgp12X654560. ISSN 1478-5242. PMC 3426598 . PMID 22947580.
- ^ Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Prostate Cancer: Symptoms – National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Information, National Center for Biotechnology; Pike, U. S. National Library of Medicine 8600 Rockville; MD, Bethesda; Usa, 20894. "Testicular Cancer: Symptoms – National Library of Medicine". PubMed Health. Retrieved 2016-01-17.
- ^ Clohisy, Denis R.; Mantyh, Patrick W. (2003-10-01). "Bone cancer pain". Clinical Orthopaedics and Related Research (415 Suppl): S279–288. doi:10.1097/01.blo.0000093059.96273.56. ISSN 0009-921X. PMID 14600620.
- ^ Vuckovic, J.; Zemunik, T.; Forenpoher, G.; Knezevic, N.; Stula, N.; Dubravcic, M.; Capkun, V. (1994-04-01). "Prognostic value of B-symptoms in low-grade non-hodgkin's lymphomas". Leukemia & Lymphoma. 13 (3–4): 357–358. doi:10.3109/10428199409056302. ISSN 1042-8194. PMID 8049656.
- ^ Givan, Alice L. (2011-01-01). "Flow cytometry: an introduction". Methods in Molecular Biology (Clifton, N.J.). 699: 1–29. doi:10.1007/978-1-61737-950-5_1. ISSN 1940-6029. PMID 21116976.
- ^ Mrózek, Krzysztof; Heerema, Nyla A.; Bloomfield, Clara D. (2004-06-01). "Cytogenetics in acute leukemia". Blood Reviews. 18 (2): 115–136. doi:10.1016/S0268-960X(03)00040-7. ISSN 0268-960X. PMID 15010150.
- ^ Bacher, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Haferlach, Torsten (2009-01-01). "Molecular diagnostics in acute leukemias". Clinical Chemistry and Laboratory Medicine. 47 (11): 1333–1341. doi:10.1515/CCLM.2009.324. ISSN 1437-4331. PMID 19817644.
- ^ Eberle, Franziska C.; Mani, Haresh; Jaffe, Elaine S. (2009-04-01). "Histopathology of Hodgkin's lymphoma". Cancer Journal (Sudbury, Mass.). 15 (2): 129–137. doi:10.1097/PPO.0b013e31819e31cf. ISSN 1528-9117. PMID 19390308.
- ^ Rao, I. Satish (2010-01-01). "Role of immunohistochemistry in lymphoma". Indian Journal of Medical and Paediatric Oncology. 31 (4): 145–147. doi:10.4103/0971-5851.76201. ISSN 0971-5851. PMC 3089924 . PMID 21584221.
- ^ Arber, Daniel A. (2000-11-01). "Molecular Diagnostic Approach to Non-Hodgkin's Lymphoma". The Journal of molecular diagnostics : JMD. 2 (4): 178–190. doi:10.1016/s1525-1578(10)60636-8. ISSN 1525-1578. PMC 1906917 . PMID 11232108.
- ^ Hande, K. R.; Garrow, G. C. (1993-02-01). "Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma". The American Journal of Medicine. 94 (2): 133–139. doi:10.1016/0002-9343(93)90174-n. ISSN 0002-9343. PMID 8430709.
- ^ D'souza, Maria M; Jaimini, Abhinav; Bansal, Abhishek; Tripathi, Madhavi; Sharma, Rajnish; Mondal, Anupam; Tripathi, Rajendra Prashad (2013-01-01). "FDG-PET/CT in lymphoma". The Indian Journal of Radiology & Imaging. 23 (4): 354–365. doi:10.4103/0971-3026.125626. ISSN 0971-3026. PMC 3932580 . PMID 24604942.
- ^ Kumar, Suneet; Rau, Aarathi R.; Naik, Ramadas; Kini, Hema; Mathai, Alka M.; Pai, Muktha R.; Khadilkar, Urmila N. (2009-09-01). "Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study". Indian Journal of Pathology & Microbiology. 52 (3): 332–338. doi:10.4103/0377-4929.54987. ISSN 0974-5130. PMID 19679954.
- ^ Pillai, R.; Kannan, S.; Chandran, G. J. (1993-04-01). "The immunohistochemistry of solid tumours: potential problems for new laboratories". The National Medical Journal of India. 6 (2): 71–75. ISSN 0970-258X. PMID 8477213.
- ^ Franzius, C. (2010-08-01). "FDG-PET/CT in pediatric solid tumors". The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 54 (4): 401–410. ISSN 1824-4785. PMID 20823808.
- ^ a b Bassetto, M. A.; Franceschi, T.; Lenotti, M.; Parise, G.; Pancheri, F.; Sabbioni, R.; Zaninelli, M.; Cetto, G. L. (1994-01-01). "AFP and HCG in germ cell tumors". The International Journal of Biological Markers. 9 (1): 29–32. ISSN 0393-6155. PMID 7519651.
- ^ Barone, C.; Astone, A.; Cassano, A.; Garufi, C.; Astone, P.; Grieco, A.; Noviello, M. R.; Ricevuto, E.; Albanese, C. (1990-01-01). "Advanced colon cancer: staging and prognosis by CEA test". Oncology. 47 (2): 128–132. ISSN 0030-2414. PMID 2314825.
- ^ Scholler, Nathalie; Urban, Nicole (2007-12-01). "CA125 in Ovarian Cancer". Biomarkers in medicine. 1 (4): 513–523. doi:10.2217/17520363.1.4.513. ISSN 1752-0363. PMC 2872496 . PMID 20477371.
- ^ Gjertson, Carl K.; Albertsen, Peter C. (2011-01-01). "Use and assessment of PSA in prostate cancer". The Medical Clinics of North America. 95 (1): 191–200. doi:10.1016/j.mcna.2010.08.024. ISSN 1557-9859. PMID 21095422.
- ^ a b Breast Cancer Treatment (PDQ®): Patient Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389406.
- ^ Cervical Cancer Treatment (PDQ®): Health Professional Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389493.
- ^ Endometrial Cancer Treatment (PDQ®): Patient Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389334.
- ^ Aletti, Giovanni D.; Gallenberg, Mary M.; Cliby, William A.; Jatoi, Aminah; Hartmann, Lynn C. (2007-06-01). "Current management strategies for ovarian cancer". Mayo Clinic Proceedings. 82 (6): 751–770. doi:10.4065/82.6.751. ISSN 0025-6196. PMID 17550756.
- ^ Non-Small Cell Lung Cancer Treatment (PDQ®): Patient Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389355.
- ^ Argiris, Athanassios; Karamouzis, Michalis V.; Raben, David; Ferris, Robert L. (2008-05-17). "Head and neck cancer". Lancet. 371 (9625): 1695–1709. doi:10.1016/S0140-6736(08)60728-X. ISSN 1474-547X. PMID 18486742.
- ^ Regalbuto, Concetto; Frasca, Francesco; Pellegriti, Gabriella; Malandrino, Pasqualino; Marturano, Ilenia; Di Carlo, Isidoro; Pezzino, Vincenzo (2012-10-01). "Update on thyroid cancer treatment". Future Oncology (London, England). 8 (10): 1331–1348. doi:10.2217/fon.12.123. ISSN 1744-8301. PMID 23130931.
- ^ Esophageal Cancer Treatment (PDQ®): Health Professional Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389338.
- ^ Gastric Cancer Treatment (PDQ®): Patient Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389328.
- ^ Wagner, Anna Dorothea; Syn, Nicholas LX; Moehler, Markus; Grothe, Wilfried; Yong, Wei Peng; Tai, Bee-Choo; Ho, Jingshan; Unverzagt, Susanne (2017-08-29). Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd. doi:10.1002/14651858.cd004064.pub4/full.
- ^ Colon Cancer Treatment (PDQ®): Patient Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389319.
- ^ Rectal Cancer Treatment (PDQ®): Health Professional Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389402.
- ^ Adult Primary Liver Cancer Treatment (PDQ®): Patient Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389251.
- ^ Pancreatic Cancer Treatment (PDQ®): Patient Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389396.
- ^ Skin Cancer Treatment (PDQ®): Patient Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389265.
- ^ Jonasch, Eric (2015-05-01). "Kidney cancer: current and novel treatment options". Journal of the National Comprehensive Cancer Network: JNCCN. 13 (5 Suppl): 679–681. ISSN 1540-1413. PMID 25995429.
- ^ Bladder Cancer Treatment (PDQ®): Health Professional Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389399.
- ^ Prostate Cancer Treatment (PDQ®): Patient Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389353.
- ^ Testicular Cancer Treatment (PDQ®): Health Professional Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389220.
- ^ "Osteosarcoma and MFH of Bone Treatment". National Cancer Institute. Retrieved 2016-01-17.
- ^ Adult Hodgkin Lymphoma Treatment (PDQ®): Health Professional Version. Bethesda (MD): National Cancer Institute (US). 2002-01-01. PMID 26389473.
- ^ "Adult Non-Hodgkin Lymphoma Treatment". National Cancer Institute. Retrieved 2016-01-17.
- ^ "Adult Acute Lymphoblastic Leukemia Treatment". National Cancer Institute. Retrieved 2016-01-17.
- ^ "Adult Acute Myeloid Leukemia Treatment". National Cancer Institute. Retrieved 2016-01-17.
- ^ "Chronic Lymphocytic Leukemia Treatment". National Cancer Institute. Retrieved 2016-01-17.
- ^ "Chronic Myelogenous Leukemia Treatment". National Cancer Institute. Retrieved 2016-01-17.
- ^ Kennedy, B. J. (1997-12-01). "Medical oncology as a discipline". Oncology. 54 (6): 459–462. ISSN 0030-2414. PMID 9394841.
- ^ a b c "Types of Oncologists". Cancer.Net : American Society of Clinical Oncology (ASCO). Retrieved 25 May 2013. Cite error: Invalid
<ref>tag; name "Cancer.Net" defined multiple times with different content (see the help page). - ^ Natarajan, Sundaram (2015-02-01). "Ocular oncology – A multidisciplinary specialty". Indian Journal of Ophthalmology. 63 (2): 91. doi:10.4103/0301-4738.154364. ISSN 0301-4738. PMC 4399140 . PMID 25827536.
- ^ Manganaris, Argyris; Black, Myles; Balfour, Alistair; Hartley, Christopher; Jeannon, Jean-Pierre; Simo, Ricard (2009-07-01). "Sub-specialty training in head and neck surgical oncology in the European Union". European Archives of Oto-Rhino-Laryngology. 266 (7): 1005–1010. doi:10.1007/s00405-008-0832-4. ISSN 1434-4726. PMID 19015865.
- ^ Harish, Krishnamachar; Kirthi Koushik, Agrahara Sreenivasa (2015-05-01). "Multidisciplinary teams in thoracic oncology-from tragic to strategic". Annals of Translational Medicine. 3 (7). doi:10.3978/j.issn.2305-5839.2015.01.31. ISSN 2305-5839. PMC 4430737 . PMID 26015931.
- ^ Mulder, Chris Jacob Johan; Peeters, Marc; Cats, Annemieke; Dahele, Anna; Droste, Jochim Terhaar sive (2011-03-07). "Digestive oncologist in the gastroenterology training curriculum". World Journal of Gastroenterology : WJG. 17 (9): 1109–1115. doi:10.3748/wjg.v17.i9.1109. ISSN 1007-9327. PMC 3063902 . PMID 21556128.
- ^ Weber, Kristy L.; Gebhardt, Mark C. (2003-04-01). "What's new in musculoskeletal oncology". The Journal of Bone and Joint Surgery. American Volume. 85–A (4): 761–767. ISSN 0021-9355. PMID 12672857.
- ^ Bukowski, Ronald M. (2011-10-10). "Genitourinary Oncology: Current Status and Future Challenges". Frontiers in Oncology. 1. doi:10.3389/fonc.2011.00032. ISSN 2234-943X. PMC 3355990 . PMID 22649760.
- ^ Benedetti-Panici, P.; Angioli, R. (2004-01-01). "Gynecologic oncology specialty". European Journal of Gynaecological Oncology. 25 (1): 25–26. ISSN 0392-2936. PMID 15053057.
- ^ Wolff, J. A. (1991-06-01). "History of pediatric oncology". Pediatric Hematology and Oncology. 8 (2): 89–91. ISSN 0888-0018. PMID 1863546.
- ^ Mkrtchyan, L. N. (2010-06-01). "On a new strategy of preventive oncology". Neurochemical Research. 35 (6): 868–874. doi:10.1007/s11064-009-0110-x. ISSN 1573-6903. PMID 20119639.
- ^ Vijaykumar, D. K.; Anupama, R.; Gorasia, Tejal Kishor; Beegum, T. R. Haleema; Gangadharan, P. (2012-01-01). "Geriatric oncology: The need for a separate subspecialty". Indian Journal of Medical and Paediatric Oncology. 33 (2): 134–136. ISSN 0971-5851. PMC 3439792 . PMID 22988358.
- ^ Epstein, A. S.; Morrison, R. S. (2012-04-01). "Palliative oncology: identity, progress, and the path ahead". Annals of Oncology. 23 Suppl 3: 43–48. doi:10.1093/annonc/mds087. ISSN 1569-8041. PMC 3493143 . PMID 22628415.
- ^ Jenkins, Robert (2001-04-01). "Principles of Molecular Oncology". American Journal of Human Genetics. 68 (4): 1068. doi:10.1086/319526. ISSN 0002-9297. PMC 1275628 .
- ^ Breen, Matthew (2009-08-01). "Update on genomics in veterinary oncology". Topics in Companion Animal Medicine. 24 (3): 113–121. doi:10.1053/j.tcam.2009.03.002. ISSN 1938-9736. PMC 2754151 . PMID 19732729.
- ^ Hill, J. M.; Meehan, K. R. (1999-09-01). "Chronic myelogenous leukemia. Curable with early diagnosis and treatment". Postgraduate Medicine. 106 (3): 149–152, 157–159. doi:10.3810/pgm.1999.09.686. ISSN 0032-5481. PMID 10494272.
- ^ Armitage, James O. (2012-02-01). "My Treatment Approach to Patients With Diffuse Large B-Cell Lymphoma". Mayo Clinic Proceedings. 87 (2): 161–171. doi:10.1016/j.mayocp.2011.11.007. ISSN 0025-6196. PMC 3497705 . PMID 22305028.
- ^ Masters, John R. W.; Köberle, Beate (2003-07-01). "Curing metastatic cancer: lessons from testicular germ-cell tumours". Nature Reviews. Cancer. 3 (7): 517–525. doi:10.1038/nrc1120. ISSN 1474-175X. PMID 12835671.
- ^ "National Surgical Adjuvant Breast and Bowel Project (NSABP)". www.nsabp.pitt.edu. Retrieved 2016-01-17.
- ^ Home – Medical Research Council
- ^ EORTC
Bibliography
- Watson, Ian R.; Takahashi, Koichi; Futreal, P. Andrew; Chin, Lynda (2013). "Emerging patterns of somatic mutations in cancer". Nat Rev Genet. 14 (10): 703–718. doi:10.1038/nrg3539. PMC 4014352 . PMID 24022702.
- Meyerson, Matthew; Gabriel, Stacey; Getz, Gad (2010). "Advances in understanding cancer genomes through second-generation sequencing". Nat Rev Genet. 11 (10): 685–696. doi:10.1038/nrg2841. PMID 20847746.
- Katsanis, Sara Huston; Katsanis, Nicholas (2013). "Molecular genetic testing and the future of clinical genomics". Nat Rev Genet. 14 (6): 415–426. doi:10.1038/nrg3493. PMC 4461364 . PMID 23681062.
- Mardis, Elaine R. (2012). "Applying next-generation sequencing to pancreatic cancer treatment". Nat Rev Gastroenterol Hepatol. 9 (8): 477–486. doi:10.1038/nrgastro.2012.126. PMID 22751458.
- Mukherjee, Siddhartha (2011). The Emperor of All Maladies: A Biography of Cancer. Fourth Estate. ISBN 978-0-00-725092-9.
- Vickers, Andrew (1 March 2004). "Alternative Cancer Cures: "Unproven" or "Disproven"?". CA: A Cancer Journal for Clinicians. 54 (2): 110–118. doi:10.3322/canjclin.54.2.110. PMID 15061600.
External links
- "Comprehensive Cancer Information". National Cancer Institute. Retrieved 2016-01-16. <
- "NCCN - Evidence-Based Cancer Guidelines, Oncology Drug Compendium, Oncology Continuing Medical Education". National Comprehensive Cancer Network. Retrieved 2016-01-16.
- "European Society for Medical Oncology | ESMO". www.esmo.org. Retrieved 2016-01-16.
Medicine
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||
| Specialties and |
|
||||||||||||||||||||
| Medical education |
|
||||||||||||||||||||
| Related topics |
|
||||||||||||||||||||
|
|||||||||||||||||||||
Overview of tumors, cancer and oncology (C00–D48, 140–239)
|
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Conditions |
|
||||||||||
| Staging/grading |
|
||||||||||
| Carcinogenesis |
|
||||||||||
| Misc. |
|
||||||||||
- Biology portal
- Medicine portal
| Authority control |
|
|---|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 成人における抗癌剤の投与 dosing of anticancer agents in adults
- 2. 最新の診療アップデート practice changing updates
- 3. 癌免疫療法の原則 principles of cancer immunotherapy
- 4. 癌生存者用ケアの質の保証：癌と共生するためのケアプラン assuring quality of care for cancer survivors the survivorship care plan
- 5. 腫瘍学の最新情報 whats new in oncology
English Journal
- Bioactivity of Meeker and Willamette raspberry (Rubus idaeus L.) pomace extracts.
- Cetojević-Simin DD1, Velićanski AS2, Cvetković DD2, Markov SL2, Cetković GS2, Tumbas Šaponjac VT2, Vulić JJ2, Canadanović-Brunet JM2, Djilas SM2.
- Food chemistry.Food Chem.2015 Jan 1;166:407-13. doi: 10.1016/j.foodchem.2014.06.063. Epub 2014 Jun 19.
- Taking into account the substantial potential of raspberry processing by-products, pomace extracts from two raspberry cultivars, Meeker and Willamette, were investigated. Total phenolic, flavonoid and anthocyanin contents were determined. Willamette pomace extract (EC50=0.042mg/ml) demonstrated stro
- PMID 25053074
- Phenolic profile, antioxidant, anti-inflammatory and cytotoxic activities of black (Tuber aestivum Vittad.) and white (Tuber magnatum Pico) truffles.
- Beara IN1, Lesjak MM2, Cetojević-Simin DD3, Marjanović ZS4, Ristić JD2, Mrkonjić ZO2, Mimica-Dukić NM2.
- Food chemistry.Food Chem.2014 Dec 15;165:460-6. doi: 10.1016/j.foodchem.2014.05.116. Epub 2014 Jun 2.
- The aim of this study was a comprehensive investigation on phenolic profile, antioxidant, anti-inflammatory and cytotoxic activity of the still insufficiently explored black summer truffles (Tuber aestivum Vittad.) and white (Tuber magnatum Pico) truffles. Methanol and water extracts, obtained by ma
- PMID 25038699
- Molecular effect of ethanol during neural differentiation of human embryonic stem cells in vitro.
- Kim JJ1, Duan L2, Tu TG1, Elie O1, Kim Y1, Mathiyakom N1, Elashoff D2, Kim Y3.
- Genomics data.Genom Data.2014 Dec 1;2:139-143.
- Potential teratogenic effects of alcohol on fetal development have been documented. Especially studies have demonstrated deleterious effect of ethanol exposure on neuronal development in animal models and on the maintenance and differentiation of neuronal precursor cells derived from stem cells. To
- PMID 25089259
Japanese Journal
- 流れに関係する呼吸生理学と癌転移 (第1土曜特集 メカノバイオロジーからメカノメディシンへ)
- 医学のあゆみ 257(10), 1070-1078, 2016-06-04
- NAID 40020838703
- Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria
- Surgery today 46(6), 668-685, 2016-06
- NAID 120005770819
- NEWS & VIEWS 薬物療法 : がんの前臨床 : 報告の透明性の必要性
- Nature reviews. Cancer, clinical oncology
- NAID 40020867630
Related Links
- Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the transla ... Oncology Journal Abbreviation ...
- JCOG（日本臨床腫瘍研究グループ）は、国立がん研究センター研究開発費（旧がん研究助成金）研究班を中心とする共同研究グループで、国立がん研究センター研究支援センターが研究を直接支援する研究班の集合体です。がんに対する ...
Related Pictures
★リンクテーブル★
| 国試過去問 | 「105F015」 |
| リンク元 | 「oncologic」「腫瘍学」「oncological」「腫瘍内科学」「オンコロジー」 |
| 拡張検索 | 「radiation oncology」「medical oncology」「psychooncology」 |
「105F015」
- 疾患と診療分野の組合せで適切でないのはどれか。
B
※国試ナビ4※ ［105F014］←［国試_105］→［105F016］
「oncologic」
- adj.
- 腫瘍の、腫瘍学の
「腫瘍学」
「oncological」
- adj.
- 腫瘍学的な、腫瘍学の
「腫瘍内科学」
「オンコロジー」
「radiation oncology」
「medical oncology」
- 関
- oncology